ATE119043T1 - Pharmazeutisches produkt für die behandlung von sepsis. - Google Patents

Pharmazeutisches produkt für die behandlung von sepsis.

Info

Publication number
ATE119043T1
ATE119043T1 AT90913206T AT90913206T ATE119043T1 AT E119043 T1 ATE119043 T1 AT E119043T1 AT 90913206 T AT90913206 T AT 90913206T AT 90913206 T AT90913206 T AT 90913206T AT E119043 T1 ATE119043 T1 AT E119043T1
Authority
AT
Austria
Prior art keywords
antibody
sepsis
specific
treatment
lps
Prior art date
Application number
AT90913206T
Other languages
English (en)
Inventor
Mark William Bodmer
Steven Michael Rhode Isla Opal
Brewster Street Division
Alan S C O Walter Reed A Cross
Research Of
Jerald C O Walter Reed Sadoff
Original Assignee
Celltech Ltd
Mark William Bodmer
Opal Steven Michael
Cross Alan S
Sadoff Jerald C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Ltd, Mark William Bodmer, Opal Steven Michael, Cross Alan S, Sadoff Jerald C filed Critical Celltech Ltd
Application granted granted Critical
Publication of ATE119043T1 publication Critical patent/ATE119043T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ink Jet (AREA)
  • Treatment Of Biological Wastes In General (AREA)
  • Finger-Pressure Massage (AREA)
AT90913206T 1989-08-10 1990-08-10 Pharmazeutisches produkt für die behandlung von sepsis. ATE119043T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918232A GB8918232D0 (en) 1989-08-10 1989-08-10 Pharmaceutical product for the treatment of septic shock

Publications (1)

Publication Number Publication Date
ATE119043T1 true ATE119043T1 (de) 1995-03-15

Family

ID=10661418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913206T ATE119043T1 (de) 1989-08-10 1990-08-10 Pharmazeutisches produkt für die behandlung von sepsis.

Country Status (10)

Country Link
EP (1) EP0486609B1 (de)
JP (1) JPH05505592A (de)
AT (1) ATE119043T1 (de)
AU (2) AU651320B2 (de)
DE (1) DE69017455T2 (de)
DK (1) DK0486609T3 (de)
ES (1) ES2071827T3 (de)
GB (2) GB8918232D0 (de)
WO (1) WO1991001755A1 (de)
ZA (1) ZA906345B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163032C (en) 1993-06-03 2001-02-06 John Landon Antibody fragments in therapy
AU7194894A (en) * 1993-07-20 1995-02-20 Sumio Arai Endotoxin neutralizer
DK0710118T3 (da) * 1994-04-20 1999-08-09 Us Army Vaccine mod infektioner med gram-negative bakterier
US6858211B1 (en) * 1998-07-20 2005-02-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccines against Escherichia coli O157 infection
DE19913707A1 (de) * 1999-03-26 2000-10-05 Privates Inst Bioserv Gmbh Immunadsorber zur Sepsistherapie
RU2199115C2 (ru) * 2000-07-10 2003-02-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ прогноза развития инфекции и тяжелых инфекционных осложнений у больных гемобластозами на программной полихимиотерапии
AU2002221099A1 (en) * 2000-12-08 2002-06-18 Takeda Chemical Industries Ltd. Combination drugs
US8420783B2 (en) 2004-12-08 2013-04-16 Immunomedics, Inc. Method and compositions for immunotherapy of inflammatory and immune-dysregulatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
JP2638652B2 (ja) * 1988-07-18 1997-08-06 カイロン・コーポレーション カケクチンと反応するモノクロナール抗体
EP0355067A1 (de) * 1988-08-19 1990-02-21 Celltech Limited Arzneimittel gegen bösartige Gewebeneubildung
ATE147634T1 (de) * 1988-12-19 1997-02-15 American Cyanamid Co Produkte zur behandlung des endotoxin -schocks bei einem säugetier

Also Published As

Publication number Publication date
AU6350090A (en) 1991-03-11
GB2251187A (en) 1992-07-01
DE69017455T2 (de) 1995-06-29
EP0486609B1 (de) 1995-03-01
DE69017455D1 (de) 1995-04-06
GB2251187B (en) 1993-06-23
WO1991001755A1 (en) 1991-02-21
AU7590694A (en) 1995-01-27
DK0486609T3 (da) 1995-05-08
JPH05505592A (ja) 1993-08-19
GB9202615D0 (en) 1992-03-25
EP0486609A1 (de) 1992-05-27
ES2071827T3 (es) 1995-07-01
AU651320B2 (en) 1994-07-21
GB8918232D0 (en) 1989-09-20
ZA906345B (en) 1992-04-29

Similar Documents

Publication Publication Date Title
NO901679D0 (no) Fremgangsmaate for fremstilling av et produkt analogt til glassaalen og produktet oppnaadd paa den maaten.
PT86509A (fr) Procede de preparation de complexes phospholipidiques d:extraits de vitis vinifera
DK436781A (da) Immunoanalysemetode og produkt til brug derved
EP0668772A4 (de) Spezifische modulationen des immunsystems.
DE69017455D1 (de) Pharmazeutisches produkt für die behandlung von sepsis.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
RU94024566A (ru) Способ модификации, способ обеспечения связывания белка с антителом, фармацевтические композиции, способ диагностики
NO884139D0 (no) Behandlingsparameter-generator for syntetisk aperturradar.
DE3650088D1 (de) Inhibin und dessen reinigung.
ES2032917T3 (es) Agente y procedimiento para la induccion de una unmunorreaccion respecto de la gnrh e inmunoesterilizacion de mamiferos.
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
DK199779A (da) Renset antigen til undersoegelse for neisseria gonorrhoeae antistoffer
BR9202323A (pt) Gel e processo para a sua preparacao
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
SE8802673D0 (sv) Anti-denatureringsmedel for etliga pastaprodukter
DE3380629D1 (en) Region-specific determinants for vitamin k dependent bone protein
BR0015287A (pt) Moléculas recombinantes de fusão
DE69100293D1 (de) Verfahren zur Herstellung von direkt stabilen Säften, Ölen und Trestern durch Auspressung von frischen biologischen Produkten.
ES8505406A1 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
DE69028094D1 (de) Konjugate von antikörpern mit variablen domänen
FI961584A0 (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
ES2062175T3 (es) Medicamentos y productos dieteticos con contenido de nuevos derivados de acilaminoacidos.
NL7809952A (nl) Vezelvormig produkt van melkproteine en een bereidings- wijze daarvoor.
RU94041049A (ru) Способ панкреатодуоденальной резекции
ES2063056T3 (es) Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee